News
Shareholders might have noticed that Cencora, Inc. (NYSE:COR) filed its quarterly result this time last week. The early response was not positive, with shares down 3.1% to US$283 in the past week.
Cencora Enjoys Strong Momentum From GLP-1s, Healthy Utilization Trends, and Growing Specialty Assets
Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $250 billion in annual US healthcare distribution sales, the firm ...
Healthcare distributor Cencora (NYSE:COR) will be reporting earnings tomorrow before the bell. Here’s what to expect. Cencora beat analysts’ revenue expectations by 5.2% last quarter ...
Healthcare distributor Cencora (NYSE:COR) will be reporting earnings tomorrow before the bell. Here’s what to expect. Cencora beat analysts’ revenue expectations by 5.2% last quarter, reporting ...
Alto and Cencora are collaborating to deliver enhanced patient support services and streamline access to prescribed specialty medications. The collaboration leverages Cencora’s patient support ...
Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...
Cencora has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale ...
Feb 5 (Reuters) - Drug distributor Cencora (COR.N), opens new tab raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines. The Conshohocken ...
Cencora, Inc. (NYSE:COR), a $47.7 billion market cap leader in the wholesale drug distribution industry, disclosed today that two of its long-standing board members, Richard W. Gochnauer and ...
Cencora, Inc. COR recently completed the previously announced acquisition of Retina Consultants of America (“RCA”), a leading management services organization (“MSO”) of retina specialists ...
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the completion of its previously announced acquisition of Retina Consultants of America (“RCA”), a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results